SA1211
/ Suzhou Siran Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 11, 2025
SA1211 Injection Phase 1 Study
(clinicaltrials.gov)
- P1 | N=80 | Recruiting | Sponsor: Suzhou Siran Biotechnology Co.,Ltd.
New P1 trial • Hepatitis B • Infectious Disease • Inflammation
1 to 1
Of
1
Go to page
1